Plaque, Amyloid: Clinical Trials

272 trials for Plaque, Amyloid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

177 completed, 28 unknown, 26 recruiting, 13 not yet recruiting. 82 Not applicable, 47 Phase 2, 46 Phase 3, 27 Phase 1, 20 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable82Completed 54, Unknown 10, Recruiting 6, Not yet recruiting 3, Terminated 3, Withdrawn 3, Enrolling by invitation 2, Active not recruiting 1
Phase 247Completed 28, Recruiting 5, Terminated 5, Unknown 4, Not yet recruiting 3, Active not recruiting 1, Suspended 1
Phase 346Completed 36, Recruiting 4, Active not recruiting 2, Unknown 2, Not yet recruiting 1, Terminated 1
Phase 127Completed 16, Not yet recruiting 3, Recruiting 3, Unknown 2, Withdrawn 2, Terminated 1
Phase 420Completed 13, Unknown 3, Recruiting 2, Not yet recruiting 1, Withdrawn 1
Early Phase 12Completed 1, Unknown 1

Follow Plaque, Amyloid: new trials by email Literature Review of Plaque, Amyloid trials Research Report on Plaque, Amyloid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AV-1959R Vaccine in Individuals With Preclinical Alzheimer's Disease
AV-1959R, Placebo - Preclinical Alzheimer's Disease, Alzheimer Disease
Phase 2Not yet recruitingInstitute for Molecular Medicine1602027-10-012026-10-21
Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis
IRX4204, Placebo - Psoriasis, Plaque Type Psorisis
Phase 2SuspendedIo Therapeutics202027-03-012026-11-12
A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease
GAL-101 Salt, Placebo - Mild to Moderate Alzheimer's Disease
Phase 2Not yet recruitingGalimedix Therapeutics Inc1002027-02-282026-08-27
Postsurgical Pain and Opioid Use in Older Adults: Effects of Mild Cognitive Impairment
Mild Cognitive Impairment (MCI), Opioid Use
Not yet recruitingMiklos Kertai5522027-01-012026-10-21
Efficacy of Two Brushing Regimens in the Reduction of Established Dental Plaque and Gingivitis
0.412% stannous fluoride toothpaste and flat trimmed toothbrush, 0.76% Na MFP and flat trimmed toothbrush - Plaque, Gingivitis
Phase 3CompletedColgate Palmolive842026-10-092026-11-10
Ceramol PSOR Cream as an Adjuvant Treatment in Patients With Mild-to-Moderate Psoriasis Treated With Narrowband UVB Phototherapy (CERAMOL PSOR CREMA)
Narrowband UVB Phototherapy, Ceramol PSOR Cream, Comparator Emollient Cream - Psoriasis, Psoriasis; Plaque
Not applicableNot yet recruitingUnifarco SpA1282026-10-012026-09-30
A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)
LY4560736, Placebo, Florbetapir F18 - Healthy Volunteers, Alzheimer Disease
Phase 1Not yet recruitingEli Lilly and Company1112026-10-012026-10-08
Clinical Study Examining the Control of Plaque and Gingivitis
Silica Free Meridol, Meridol, Colgate Dental Product - Gingivitis
Phase 3Not yet recruitingColgate Palmolive1352026-10-012026-09-25
Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients
8M2D, Placebo - Alzheimer's Disease (AD)
Phase 1Not yet recruitingCenna Biosciences Inc.542026-09-152026-05-05
Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
Mazdutide, Placebo - Obesity & Overweight, Coronary Heart Disease
Phase 4RecruitingChina National Center for Cardiovascular Diseases1162026-09-142026-10-13
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
LY4405094, Placebo, Florbetapir F18 - Alzheimer Disease, Amyloid
Phase 1RecruitingEli Lilly and Company1792026-09-092026-11-05
Multimodality Optical and Ultrasound Intravascular Imaging for Stent Optimization and Atheroma Assessment
Conavi Medical Novasight Hybrid System intervention - Coronary Artery Disease, Coronary Stenosis
Not applicableWithdrawnBarts & The London NHS Trust2026-09-012025-09-17
Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation
Donanemab, Placebo - Down Syndrome (DS), Down Syndrome (Trisomy 21)
Phase 4Not yet recruitingMichael Rafii, MD, PhD602026-08-012026-05-15
Clinical Evaluation of a Toothpaste for Dental Plaque Reduction and Prevention of Gum Problems
0.45% SnF HW with NaF (1450 F), 67% Bicarbonate with NaF (1400 F), Colgate Cavity Protection Toothpaste - Plaque, Dental Plaque
Phase 3RecruitingColgate Palmolive1202026-07-202026-09-25
Oil Pulling Reduction
GuruNanda natural Oil Pulling oral rinse, TheraBreath Plaque Control Oral Rinse, GuruNanda water-based non-whitening mouthwash - Good Health, Gingival Inflammation and Bleeding
Not applicableRecruitingThe University of Texas Health Science Center at San Antonio1202026-07-082026-08-24
Restoring Cervical Lymphatic Drainage in Alzheimer's Disease
Cervical lymphovenous anastomosis (LVA) - Alzheimer, Alzheimer Dementia (AD)
Not applicableRecruitingUniversity of Siena52026-07-012026-10-02
Assessing the Influence of Habitual Beef Intake on Key Molecular Markers of Brain Health
Lean Beef, Non-Beef Control - Healthy Aging, Brain Health
Not applicableRecruitingSouth Dakota State University202026-06-032026-06-03
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Donanemab, Placebo - Alzheimer Disease, Dementia
Phase 3RecruitingEli Lilly and Company5502026-05-222026-10-28
Study to Investigate Toothpaste on Antibacterial Effects in the Different Regions of the Mouth
stannous fluoride toothpaste, 0.76% Sodium Monofluorophosphate (Na MFP) toothpaste - Plaque, Gingivitis
Phase 3CompletedColgate Palmolive952026-05-182026-09-24
DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community
Alzheimer Disease, Cognitive Dysfunction, Cognitive Disorder
Not yet recruitingBarcelonabeta Brain Research Center, Pasqual Maragall Foundation2502026-04-272026-04-13

Showing 20 of 272. Sign in to see all of them.

Narrower conditions

Alzheimer Disease (72)  ·  Gingivitis (56)  ·  Dementia (29)  ·  Psoriasis (27)  ·  Cognitive Dysfunction (25)  ·  Dental Plaque (16)  ·  Atherosclerosis (14)  ·  Coronary Artery Disease (14)  ·  Pick Disease of the Brain (14)  ·  Gingival Hemorrhage (11)  ·  Pruritus (10)  ·  Dental Caries (9)  ·  Periodontitis (9)  ·  Skin Diseases (9)

Broader conditions

Pathological Conditions, Anatomical (272)  ·  Pathological Conditions, Signs and Symptoms (272)  ·  Nervous System Diseases (93)  ·  Central Nervous System Diseases (88)  ·  Brain Diseases (87)  ·  Stomatognathic Diseases (86)  ·  Neurocognitive Disorders (77)  ·  Mental Disorders (76)  ·  Mouth Diseases (70)  ·  Neurodegenerative Diseases (70)  ·  Tauopathies (68)  ·  Periodontal Diseases (64)  ·  Gingival Diseases (59)  ·  Infections (59)  ·  Dementia (47)

Interventions

secukinumab (15)  ·  4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene (10)  ·  florbetapir (7)  ·  7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (5)  ·  Atorvastatin (4)  ·  Sugars (4)  ·  donanemab (4)  ·  Chlorhexidine (3)  ·  Magnetic Resonance Spectroscopy (3)  ·  Supersmile (3)  ·  hydrated silica gel-based toothpaste (3)  ·  Dentifrices (2)  ·  Endarterectomy, Carotid (2)  ·  Fluorides (2)  ·  Fluorodeoxyglucose F18 (2)

Sponsors

Novartis Pharmaceuticals (16)  ·  Colgate Palmolive (15)  ·  Eli Lilly and Company (9)  ·  Koite Health Oy (6)  ·  University of Southern California (6)  ·  Home Skinovations Ltd. (4)  ·  I.R.A. Istituto Ricerche Applicate S.p.A. (4)  ·  Lantheus Biosciences Ltd. (4)  ·  Pfizer (4)  ·  Procter and Gamble (4)  ·  University of California, Los Angeles (4)  ·  Al-Mustansiriyah University (3)  ·  Chang Gung Memorial Hospital (3)  ·  Johnson & Johnson Consumer Inc. (J&JCI) (3)  ·  University of Florida (3)

Countries

United States (114)  ·  Canada (28)  ·  Germany (24)  ·  Japan (18)  ·  France (17)  ·  Spain (17)  ·  United Kingdom (17)  ·  Italy (16)  ·  China (12)  ·  Netherlands (12)  ·  Taiwan (11)  ·  Czechia (10)  ·  Australia (9)  ·  Israel (9)  ·  Belgium (8)

Top investigators

Mihaela Fratila (4)  ·  Paul Aisen, MD (4)  ·  Timo Sorsa, Professor (4)  ·  Brendan Lucey, MD (3)  ·  Chhaju Ram Goyal, DDS (2)  ·  Marcelle Nascimento, DDS, MS, PhD (2)  ·  Michael W. Weiner, MD (2)  ·  Ming-Jang Chiu, M.D. (2)

Results publications

PMID 33773598, PMID 35305260, PMID 37341961, PMID 39324520, PMID 23640952, PMID 27573260, PMID 27576559, PMID 32791950, PMID 33748660, PMID 34110605, PMID 34187867, PMID 38853879, PMID 39219209, PMID 42862762, PMID 14326695, PMID 16564083, PMID 17183151, PMID 20598972, PMID 21471671, PMID 21481640, PMID 22149222, PMID 22455413, PMID 22473769, PMID 22789936, PMID 23214115, PMID 23357149, PMID 23534323, PMID 23686372, PMID 23873319, PMID 24152824, PMID 24970906, PMID 25007392, PMID 25242558, PMID 25243910, PMID 25354738, PMID 25563640, PMID 25669746, PMID 25693783, PMID 25790876, PMID 25824567, PMID 25936321, PMID 26051365, PMID 26185328, PMID 26267726, PMID 26516010, PMID 26662044, PMID 26823561, PMID 27213629, PMID 27271195, PMID 27421618

NIH funding

2014 (2), 2015 (2), 2016 (2), 2017 (2), K23DE023579 (2), U01AG024904 (2), 1RC2AG036535-01 (1), 1RF1AG047866-01A1 (1), 1UG3DE030401-01 (1), 2009 (1), 2025 (1), 8UL1TR000114-02 (1), K01AG047279 (1), P01AG025831 (1), P50AG005134 (1)